These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 9872818

  • 1. Derivation of tumor-specific cytolytic T-cell clones from two lung cancer patients with long survival.
    Weynants P, Thonnard J, Marchand M, Delos M, Boon T, Coulie PG.
    Am J Respir Crit Care Med; 1999 Jan; 159(1):55-62. PubMed ID: 9872818
    [Abstract] [Full Text] [Related]

  • 2. Functional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinoma.
    Dorothée G, Echchakir H, Le Maux Chansac B, Vergnon I, El Hage F, Moretta A, Bensussan A, Chouaib S, Mami-Chouaib F.
    Oncogene; 2003 Oct 16; 22(46):7192-8. PubMed ID: 14562047
    [Abstract] [Full Text] [Related]

  • 3. A different pattern of cytotoxic T lymphocyte recognition against primary and metastatic tumor cells in a patient with nonsmall cell lung carcinoma.
    So T, Takenoyama M, Ichiki Y, Mizukami M, So T, Hanagiri T, Sugio K, Yasumoto K.
    Cancer; 2005 Jan 01; 103(1):200-8. PubMed ID: 15573370
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic properties of CD4(+) T-cell clones which lyse HLA class II negative autologous non-small-cell lung cancer cells.
    Semino C, Ferlazzo G, Ratto GB, Melioli G.
    Cell Immunol; 1999 Sep 15; 196(2):87-94. PubMed ID: 10527560
    [Abstract] [Full Text] [Related]

  • 5. Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.
    Dorothée G, Vergnon I, Menez J, Echchakir H, Grunenwald D, Kubin M, Chouaib S, Mami-Chouaib F.
    J Immunol; 2002 Jul 15; 169(2):809-17. PubMed ID: 12097384
    [Abstract] [Full Text] [Related]

  • 6. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan 15; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

  • 7. Antitumor cytotoxic T-lymphocyte response in human lung carcinoma: identification of a tumor-associated antigen.
    Mami-Chouaib F, Echchakir H, Dorothée G, Vergnon I, Chouaib S.
    Immunol Rev; 2002 Oct 15; 188():114-21. PubMed ID: 12445285
    [Abstract] [Full Text] [Related]

  • 8. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 9. Generation of cytotoxic T lymphocytes against autologous lung cancer cells resistant to apoptosis.
    Hiraki A, Ono T, Tanaka M, Kiura K, Ueoka H, Kawai H, Harada M, Nakayama E, Noguchi Y.
    Anticancer Res; 2001 Dec 01; 21(4A):2561-7. PubMed ID: 11724322
    [Abstract] [Full Text] [Related]

  • 10. Generation of diverse mutated tumor antigen-specific cytotoxic T lymphocytes in a lung cancer patient with long survival.
    El Hage F, Vergnon I, Grunenwald D, Soria JC, Chouaib S, Mami-Chouaib F.
    Oncol Rep; 2005 Sep 01; 14(3):763-9. PubMed ID: 16077989
    [Abstract] [Full Text] [Related]

  • 11. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB, Whiteside TL.
    Cancer Res; 1991 Nov 15; 51(22):6153-62. PubMed ID: 1718596
    [Abstract] [Full Text] [Related]

  • 12. Identification of the HLA-Cw*0702-restricted tumor-associated antigen recognized by a CTL clone from a lung cancer patient.
    Nagata Y, Hanagiri T, Takenoyama M, Fukuyama T, Mizukami M, So T, Ichiki Y, Sugaya M, Sugio K, Yasumoto K.
    Clin Cancer Res; 2005 Jul 15; 11(14):5265-72. PubMed ID: 16033845
    [Abstract] [Full Text] [Related]

  • 13. Growth and functional reactivity of lymphocytes obtained from three anatomic compartments in patients with non-small-cell lung cancer (NSCLC).
    Yannelli JR, Hirscowitz E, Wroblewski JM.
    Cancer Biother Radiopharm; 2003 Oct 15; 18(5):735-49. PubMed ID: 14629822
    [Abstract] [Full Text] [Related]

  • 14. HLA-A locus-restricted and tumor-specific CTLs in tumor-infiltrating lymphocytes of patients with non-small cell lung cancer.
    Seki N, Hoshino T, Kikuchi M, Hayashi A, Itoh K.
    Cell Immunol; 1997 Feb 01; 175(2):101-10. PubMed ID: 9023415
    [Abstract] [Full Text] [Related]

  • 15. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
    Yazawa T, Kamma H, Fujiwara M, Matsui M, Horiguchi H, Satoh H, Fujimoto M, Yokoyama K, Ogata T.
    J Pathol; 1999 Jan 01; 187(2):191-9. PubMed ID: 10365094
    [Abstract] [Full Text] [Related]

  • 16. Association of HER2/neu expression with sensitivity to tumor-specific CTL in human ovarian cancer.
    Yoshino I, Peoples GE, Goedegebuure PS, Maziarz R, Eberlein TJ.
    J Immunol; 1994 Mar 01; 152(5):2393-400. PubMed ID: 8133050
    [Abstract] [Full Text] [Related]

  • 17. High frequency of cytolytic T lymphocytes directed against a tumor-specific mutated antigen detectable with HLA tetramers in the blood of a lung carcinoma patient with long survival.
    Karanikas V, Colau D, Baurain JF, Chiari R, Thonnard J, Gutierrez-Roelens I, Goffinet C, Van Schaftingen EV, Weynants P, Boon T, Coulie PG.
    Cancer Res; 2001 May 01; 61(9):3718-24. PubMed ID: 11325844
    [Abstract] [Full Text] [Related]

  • 18. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68.
    Slingluff CL, Cox AL, Stover JM, Moore MM, Hunt DF, Engelhard VH.
    Cancer Res; 1994 May 15; 54(10):2731-7. PubMed ID: 7513255
    [Abstract] [Full Text] [Related]

  • 19. Evidence for in situ expansion of diverse antitumor-specific cytotoxic T lymphocyte clones in a human large cell carcinoma of the lung.
    Echchakir H, Vergnon I, Dorothée G, Grunenwald D, Chouaib S, Mami-Chouaib F.
    Int Immunol; 2000 Apr 15; 12(4):537-46. PubMed ID: 10744655
    [Abstract] [Full Text] [Related]

  • 20. The induction of cytotoxic T lymphocytes against HLA-A locus-matched lung adenocarcinoma in patients with non-small cell lung cancer.
    Yoshino I, Takenoyama M, Fujie H, Hanagiri T, Yoshimatsu T, Imabayashi S, Eifuku R, Ogami A, Yano K, Osaki T, Nakanishi R, Ichiyoshi Y, Nomoto K, Yasumoto K.
    Jpn J Cancer Res; 1997 Aug 15; 88(8):743-9. PubMed ID: 9330606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.